Bharat Biotech launches COMVAC5 vaccines

NEW DELHI: Drug firm Bharat Biotech has launched COMVAC5, a single shot pentavalent combination vaccine used for treating diseases such as Diptheria, Pertussis, Tetnus, Hepatitis B and Haemophilus-Influenza typeb (Hib).

"COMVAC5 contains the first indigenously developed and manufactured Heamophilus type B vaccines in India and the only Hepatitis B vaccine in the world to be manufactured without the use of Cesium chloride," Bharat Biotech said in a statement today.

The company has invested around seven million dollars over the past four years in research & development (R&D) and manufacturing facilities for producing COMVAC5, it added.

Combination pentavalent vaccines have been approved by several countries across the world and are included in their respective national immunisation programmes.

"With a single injection this vaccine has the ability to protect children against multiple infectious diseases," Bharat Biotech Chairman and Managing Director Krishna M Ella said.

Hyderabad-based Bharat Biotech is one of the leading manufacturers of vaccines in the country.